OACC
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary ShareOACC
OACC
About: Oaktree Acquisition Corp III Life Sciences is a blank check company.
0
Funds holding %
of 7,245 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
360% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 5
200% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 3 (+2) [Q1 2025]
90% more funds holding
Funds holding: 20 [Q4 2024] → 38 (+18) [Q1 2025]
67% more capital invested
Capital invested by funds: $89.8M [Q4 2024] → $150M (+$59.8M) [Q1 2025]
28.59% more ownership
Funds ownership: 45.45% [Q4 2024] → 74.05% (+28.59%) [Q1 2025]
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Research analyst outlook
We haven’t received any recent analyst ratings for OACC.
Financial journalist opinion
We haven’t received any recent news articles for OACC.
Charts implemented using Lightweight Charts™